http://www.smartbrief.com/news/AANP/pressReleases.jsp?sb_code=RSS&industry=Biopharmaceuticals%20%26%20Biotherapeutics Biopharmaceuticals & Biotherapeutics Press Releases from SmartBrief Tue, 24 Nov 2009 08:05:41 CST Exelixis, Inc. (NASDAQ:EXEL) announced today that it will hold its Fifth Annual R&D Day on Wednesday, December 2, 2009 from 10:00 a.m. EST / 7:00 a.m. PST to 2:00 p.m. EST / 11:00 a.m. PST in New York. Exelixis management will discuss the company?s d... Tue, 24 Nov 2009 08:04:41 CST Tue, 24 Nov 2009 06:04:41 CST Oxagen Limited, a drug discovery and development company specializing in inflammation, announced today the successful completion of a £16 Million ($26.7 Million) Series C round led by Novartis Venture Funds. Tue, 24 Nov 2009 03:34:41 CST Mon, 23 Nov 2009 16:04:41 CST StemCells, Inc. (NASDAQ: STEM) announced today that its president and CEO, Martin McGlynn, was recently featured on BioBusiness.TV?s ?Stem Cell Review? discussing the Company?s therapeutic product development programs, including the promise of human ... Mon, 23 Nov 2009 15:34:41 CST Mon, 23 Nov 2009 09:34:41 CST StemCells, Inc. (NASDAQ: STEM) announced today that it has commenced patient recruitment for a Phase I clinical trial designed to test the safety and preliminary efficacy of its HuCNS-SC® purified human neural stem cells in Pelizaeus-Merzbacher Disea... Mon, 23 Nov 2009 08:05:41 CST Human Genome Sciences, Inc. (Nasdaq: HGSI) and Aegera Therapeutics, Inc. today announced that HGS has initiated dosing in a Phase 1 clinical trial to evaluate the safety and tolerability of its lead IAP inhibitor, HGS1029, as monotherapy in patients ... Mon, 23 Nov 2009 06:04:41 CST Mon, 23 Nov 2009 05:34:41 CST